ACT 2 Logo
FOR ATHLETES · ENDURANCE HISTORY

"I Did the Miles, My Heart Is Fine"

It is the most reasonable-sounding sentence in this whole category, and it is the one most likely to delay a useful conversation by a decade.

Endurance histories do produce a favorable picture on most of what gets measured. That part is real. What does not follow is the conclusion people draw from it — that decades of high-volume aerobic training buy immunity from the disease that kills most people.

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.

What the training genuinely bought you

Start with the credit side, because it is substantial and this page is not an argument against endurance sport.

In the 2023 scoping review of midlife former athletes published in BMJ Open Sport & Exercise Medicine, endurance backgrounds were associated with lower total cholesterol, lower triglycerides and lower glucose than comparison groups. Cardiorespiratory fitness — which is among the strongest predictors of all-cause mortality we have — tends to stay higher in people with these histories, even years after the volume drops.

That is a genuinely good hand to be holding at 52. Nothing below takes it away.

What it did not buy

MASTER@HEART compared 191 lifelong endurance athletes with 191 late-onset athletes and 176 healthy non-athletic controls — all male, median age 55 — and looked directly at their coronary arteries.

The lifelong endurance athletes had more coronary plaque, not less. More calcified plaque, more non-calcified plaque, more mixed plaque, more of it in proximal segments, and more lesions causing significant narrowing.

This needs stating carefully, because it is easy to misreport. The finding is not that running causes heart disease, and it is not an argument for training less. Exercise remains one of the best-evidenced things a person can do for long-term health. What the study undermines is a specific belief: that a lifetime of high-volume aerobic training means the coronary question is already answered.

It is not answered. It is unmeasured, which is a different thing, and it is measurable.

Why the standard panel is least useful here

The lipid panel is at its least informative in exactly this population, for a mechanical reason.

A routine panel reports an LDL-C figure that is usually calculated rather than measured — an estimate of cholesterol carried inside LDL particles. In a lean, well-trained person with high HDL and low triglycerides, that calculation tends to return a reassuring number. What it does not report is how many atherogenic particles are in circulation, which is the thing that interacts with the artery wall.

Two markers close most of that gap, and the March 2026 ACC/AHA dyslipidemia guideline addresses both. Apolipoprotein B counts the particles directly. Lipoprotein(a) is largely genetically determined, stays stable across a lifetime, and the guideline recommends measuring it at least once in adulthood — elevated Lp(a) is entirely compatible with elite fitness, because training does not move it.

If there is a single unexplained early cardiac event in your family and you have been reassured by your own fitness for twenty years, that combination is worth taking seriously.

The other thing endurance histories hide

Low testosterone in a lean former endurance athlete is one of the most commonly misread findings we see.

Sustained high training volume against inadequate fueling suppresses male reproductive hormones, and that suppression does not necessarily lift just because the racing stopped. A man who spent fifteen years chronically under-fueled and arrives at 49 with a low reading is not automatically a testosterone therapy candidate — he may have a fueling problem wearing a hormone problem's clothes.

Treating the second when it is the first is a real clinical error and it is not a rare one. It also means the underlying issue continues, now with a prescription on top of it. More on under-fueling that carried forward.

Bone is the third item. Impact loading builds bone durably, and non-impact endurance sports — cycling, swimming, rowing — do not deliver that loading. A cycling history is not a bone history. More on conditional bone protection.

What we do, and what we refer

Everyone gets the same baseline: metabolic markers, the full lipid picture, liver and kidney function, thyroid, inflammatory markers, nutrient status and hormones. What changes for an endurance history is the reading — a cardiovascular risk conversation that does not begin from the assumption of immunity, fueling addressed before hormones, and bone raised where the sport was non-impact.

What we cannot do: any imaging. No coronary calcium score, no CT angiogram, no echocardiogram, no stress test, no DEXA. If the picture warrants one — and in a strong family history with an elevated Lp(a), it may — that is a referral, and we will say so plainly rather than offering an approximation of it.

Questions

Frequently asked questions

  • No, and that is not what MASTER@HEART shows. Exercise remains strongly protective for long-term health. The finding is narrower: lifelong high-volume training does not confer the coronary immunity many endurance athletes assume it does.

  • It may be a reasonable next step depending on your risk profile and family history, and it is a decision to make with a clinician. We do not perform imaging of any kind, so if one is indicated we refer.

  • It is a good sign and it is not the whole picture. A calculated LDL-C is least reliable in exactly this body type. ApoB counts particles directly, and Lp(a) is genetic and unaffected by anything you did in training. More on both.

  • Often more, not less. Several of the relevant exposures — training load, energy availability, Lp(a) — carry forward independently of what you are doing now.

  • Not necessarily, and this is the finding most worth slowing down on in an endurance history. Chronic under-fueling suppresses these hormones, and it needs excluding before treatment is the answer.

  • No. It was entirely male, which is a real limitation and a recurring one in this literature. More on the research gap.

Your next step

Where this fits in your plan

Start with a baseline panel read against your training history rather than a reference range, and be specific about the volume years and what fueling looked like during them.

We measure first. Then we act.

References

  1. Long-term function, body composition and cardiometabolic health in midlife former athletes: a scoping review. BMJ Open Sport & Exercise Medicine, 2023.
  2. De Bosscher R et al. Lifelong endurance exercise and its relation with coronary atherosclerosis (MASTER@HEART). European Heart Journal, 2023.
  3. 2026 ACC/AHA Guideline on the Management of Dyslipidemia. Journal of the American College of Cardiology, March 2026.
  4. Blood Cholesterol. National Heart, Lung, and Blood Institute.
  5. Mountjoy M et al. 2023 International Olympic Committee consensus statement on Relative Energy Deficiency in Sport (REDs). British Journal of Sports Medicine, 2023.

How we write and review our content

ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.

Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.

We measure first. Then we act.

Start with a baseline that reads your history, not only your labs.